Literature DB >> 15533605

Serotonergic hypothesis of sleepwalking.

Grzegorz R Juszczak1, Artur H Swiergiel.   

Abstract

Despite widespread prevalence of sleepwalking, its etiology and pathophysiology are not well understood. However, there is some evidence that sleepwalking can be precipitated by sleep-disordered breathing. A hypothesis is proposed that serotonergic system may be a link between sleep-disordered breathing and sleepwalking. Serotonergic neurons meet basic requirements for such a role because they are activated by hypercapnia, provide a tonic excitatory drive that gates afferent inputs to motoneurons, and the activity of serotonergic neurons can be dissociated from the level of arousal. This paper discusses also drug-induced somnambulism and co-occurrence of sleepwalking and other disorders such as migraine and febrile illness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15533605     DOI: 10.1016/j.mehy.2004.06.013

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  11 in total

1.  Sleepwalking, a possible side effect of antipsychotic medication.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2011-03

2.  Two cases of somnambulism induced by quetiapine.

Authors:  Zeba Hasan Hafeez; Constance M Kalinowski
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

3.  Association between GABA(A) receptor subunit gene cluster and zolpidem-induced complex sleep behaviors in Han Chinese.

Authors:  Jui-Hsiu Tsai; Pinchen Yang; Hung-Hsun Lin; Kuang-Hung Cheng; Yi-Hsin Yang; Ming-Tsang Wu; Cheng-Chung Chen
Journal:  Sleep       Date:  2013-02-01       Impact factor: 5.849

4.  A preliminary survey on prevalence and knowledge about different aspects of somnambulism in Buner District of Khyber Pakhtunkhwa, Pakistan.

Authors:  Zaigham Hasan; Rabia Afridi; Lubna Rahman; Naveeda Akhtar Qureshi; Kausar Saeed; Humera Afridi
Journal:  Sleep Breath       Date:  2018-01-20       Impact factor: 2.816

Review 5.  Parasomnias: an updated review.

Authors:  Michael J Howell
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

6.  Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population.

Authors:  M M Ohayon; M W Mahowald; Y Dauvilliers; A D Krystal; D Léger
Journal:  Neurology       Date:  2012-05-15       Impact factor: 9.910

Review 7.  Therapeutic Symptomatic Strategies in the Parasomnias.

Authors:  Raffaele Manni; Gianpaolo Toscano; Michele Terzaghi
Journal:  Curr Treat Options Neurol       Date:  2018-06-05       Impact factor: 3.598

Review 8.  NonREM Disorders of Arousal and Related Parasomnias: an Updated Review.

Authors:  Muna Irfan; Carlos H Schenck; Michael J Howell
Journal:  Neurotherapeutics       Date:  2021-02-01       Impact factor: 7.620

9.  Impact of primary headaches on subjective sleep parameters among adolescents.

Authors:  Ravi Gupta; Manjeet Singh Bhatia; Devendra Dahiya; Sameer Sharma; Rahul Sapra; Kapil Semalti; Raman Preet Singh Dua
Journal:  Ann Indian Acad Neurol       Date:  2008-07       Impact factor: 1.383

Review 10.  Progress in elucidating the pathophysiological basis of nonrapid eye movement parasomnias: not yet informing therapeutic strategies.

Authors:  András Horváth; Anikó Papp; Anna Szűcs
Journal:  Nat Sci Sleep       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.